| Literature DB >> 24924953 |
Bor-Sheng Ko1, Cheng-Shyong Chang, Ming-Chih Chang, Tsai Yun Chen, Tzeon-Jye Chiou, Chang-Fang Chiu, Wen-Li Huang, Woei-Yau Kao, Yii-Jenq Lan, Shen-Fung Lin, Tran-Der Tan, Jih-Luh Tang, Cheng-Hwai Tzeng, Po-Nan Wang, Su-Pen Yet, Hwei-Fang Tien.
Abstract
Iron overload is common in myelodysplastic syndrome (MDS) patients, and an accumulation of evidence shows that iron chelation may have benefits in these patients. However, discussion and consensus about iron chelation therapy (ICT) for MDS patients is lacking in Taiwan and other Southeast Asian countries. An Expert Panel in Taiwan was organized in 2011 to develop iron overload guidelines and provide a uniform reference for physicians treating MDS patients with iron overload, with specific regard to when to initiate ICT, in which patients, and the clinical and scientific rationale behind its use.Entities:
Mesh：
Substances：
Year: 2014 PMID： 24924953 DOI： 10.1007/s12185-014-1607-x
Source DB: PubMed Journal: Int J Hematol ISSN： 0925-5710 Impact factor: 2.490